Literature DB >> 9505169

Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM).

H Halfter1, R Lotfi, R Westermann, P Young, E B Ringelstein, F T Stögbauer.   

Abstract

The neuropoietic cytokines of the interleukin-6 family are a group of structurally and functionally related polypeptides. We studied the effect of the multifunctional neuropoietic cytokines, including oncostatin M (OSM), leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), on anaplastic glioma cell lines. Growth and morphology of the glioma cell lines were affected differently. While IL-6 and LIF exerted no or only small minor morphological changes and growth retardation, OSM induced a marked change in morphology and a strong suppression of growth. OSM treated cells were characterized by enlargement and the formation of multiple, thin processes thus resembling mature cultured astrocytes. The growth inhibitory effects were dose dependent with a maximum exerted by addition of 50 ng/ml OSM. The inhibition of DNA synthesis by OSM could be abolished by antibodies blocking either the activity of OSM or the OSM-receptor component, gp130.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505169     DOI: 10.3109/08977199809117189

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  8 in total

1.  Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression.

Authors:  M M Mueller; C C Herold-Mende; D Riede; M Lange; H H Steiner; N E Fusenig
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Induction of astrocyte differentiation by endothelial cells.

Authors:  H Mi; H Haeberle; B A Barres
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

3.  CNTF and its receptor subunits in human gliomas.

Authors:  J Weis; L M Schönrock; S L Züchner; D C Lie; U Sure; C Schul; F Stögbauer; E B Ringelstein; H Halfter
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

4.  Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.

Authors:  Emma C Walker; Narelle E McGregor; Ingrid J Poulton; Melissa Solano; Sueli Pompolo; Tania J Fernandes; Matthew J Constable; Geoff C Nicholson; Jian-Guo Zhang; Nicos A Nicola; Matthew T Gillespie; T John Martin; Natalie A Sims
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

5.  Fuzzy clustering analysis of osteosarcoma related genes.

Authors:  Kai Chen; Dajiang Wu; Yushu Bai; Xiaodong Zhu; Ziqiang Chen; Chuanfeng Wang; Yingchuan Zhao; Ming Li
Journal:  Pathol Oncol Res       Date:  2013-11-30       Impact factor: 3.201

6.  Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population.

Authors:  Il Ki Hong; Young Gyu Eun; Dae Han Chung; Kee Hwan Kwon; Deog Yoon Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-12-15       Impact factor: 3.372

7.  Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.

Authors:  Zhenjia Yu; Zhen Li; Chenchen Wang; Tao Pan; Xinyu Chang; Xiaofeng Wang; Quan Zhou; Xiongyan Wu; Jianfang Li; Jinping Zhang; Bingya Liu; Zhenggang Zhu; Liping Su
Journal:  Gastric Cancer       Date:  2019-02-18       Impact factor: 7.701

8.  Hyperbaric oxygen suppresses stemness-associated properties and Nanog and oncostatin M expression, but upregulates β-catenin in orthotopic glioma models.

Authors:  Kun Song; Junrui Chen; Jianbo Ding; Hao Xu; Hongzhi Xu; Zhiyong Qin
Journal:  J Int Med Res       Date:  2019-12-09       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.